Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Engaging T cells for cleanup

View through CrossRef
T-cell engagers represent a transformative approach to cancer immunotherapy leveraging bispecific and multispecific antibody constructs to redirect T-cell cytotoxicity toward malignant cells. These molecules bridge T cells and tumor cells by simultaneously binding CD3 on T cells and tumor-associated antigens on cancer cells, thereby enabling precise immune targeting even in immunologically “cold” tumors. Recent advancements include conditional T-cell engagers activated by tumor microenvironment proteases to minimize off-tumor toxicity as well as T-cell receptor–based engagers targeting intracellular antigens via MHC presentation. Clinical successes, such as Kimmtrak in metastatic uveal melanoma, underscore good potential of these modalities, while challenges persist in the management of cytokine release syndrome, neurotoxicity, and tumor resistance. Emerging multispecific engagers are aimed at enhancing efficacy via incorporation of costimulatory signals, thus offering a promising trajectory for next-generation immunotherapies. T-cell engagers are also gaining attention in the treatment of autoimmune disorders, where they can be designed to selectively modulate pathogenic immune responses. By targeting autoreactive T or B cells, T-cell engagers hold promise for restoring immune tolerance in such conditions as HLA-B*27–associated autoimmunity subtypes, multiple sclerosis, rheumatoid arthritis, and type 1 diabetes mellitus. Engineering strategies that incorporate inhibitory receptors or tissue-specific antigens may further refine T-cell engagers’ therapeutic potential in autoimmunity, by minimizing systemic immunosuppression while preserving immune homeostasis.
Title: Engaging T cells for cleanup
Description:
T-cell engagers represent a transformative approach to cancer immunotherapy leveraging bispecific and multispecific antibody constructs to redirect T-cell cytotoxicity toward malignant cells.
These molecules bridge T cells and tumor cells by simultaneously binding CD3 on T cells and tumor-associated antigens on cancer cells, thereby enabling precise immune targeting even in immunologically “cold” tumors.
Recent advancements include conditional T-cell engagers activated by tumor microenvironment proteases to minimize off-tumor toxicity as well as T-cell receptor–based engagers targeting intracellular antigens via MHC presentation.
Clinical successes, such as Kimmtrak in metastatic uveal melanoma, underscore good potential of these modalities, while challenges persist in the management of cytokine release syndrome, neurotoxicity, and tumor resistance.
Emerging multispecific engagers are aimed at enhancing efficacy via incorporation of costimulatory signals, thus offering a promising trajectory for next-generation immunotherapies.
T-cell engagers are also gaining attention in the treatment of autoimmune disorders, where they can be designed to selectively modulate pathogenic immune responses.
By targeting autoreactive T or B cells, T-cell engagers hold promise for restoring immune tolerance in such conditions as HLA-B*27–associated autoimmunity subtypes, multiple sclerosis, rheumatoid arthritis, and type 1 diabetes mellitus.
Engineering strategies that incorporate inhibitory receptors or tissue-specific antigens may further refine T-cell engagers’ therapeutic potential in autoimmunity, by minimizing systemic immunosuppression while preserving immune homeostasis.

Related Results

The Effect of Yield Stress on Fracture Fluid Cleanup Nolte, SPE, Dowell
The Effect of Yield Stress on Fracture Fluid Cleanup Nolte, SPE, Dowell
Abstract This paper evaluates polymer fluid cleanup in general and more specifically why Cotton Valley fracture treatments recover less than one half of the injec...
Successful transfection of Lymphoblastoid cell line (Preprint)
Successful transfection of Lymphoblastoid cell line (Preprint)
BACKGROUND Immortalization is the stage that the cell goes through before full transformation [1]. Human resting B lymphocytes from peripheral blood are eas...
Cleanup to FPSO or Through a Rig in Deep Water—Pro and Cons
Cleanup to FPSO or Through a Rig in Deep Water—Pro and Cons
Abstract After the drilling and completion of every well, a crucial step involves its preparation for transfer to production. During this operation, we aim to extrac...
Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...
Developing “Off-the-Shelf” CLL1 CAR-DNT Therapeutics for the R/R Acute Myeloid Leukemia
Developing “Off-the-Shelf” CLL1 CAR-DNT Therapeutics for the R/R Acute Myeloid Leukemia
Background: Acute myeloid leukemia (AML) is one of the most common and highly heterogeneous hematological malignancy. The prognosis is poor especially for the elderly patients. For...
Megakaryocytes Support Viability Proliferation and Protection of Primary Pre-B ALL Cells from Chemotherapy
Megakaryocytes Support Viability Proliferation and Protection of Primary Pre-B ALL Cells from Chemotherapy
Abstract BACKGROUND: The bone marrow is known to shelter leukemia cells from chemotherapy and contributes to the survival of chemotherapy resistant residual cells, t...
Using Artificial Intelligence to Predict Contamination During Formation Fluid Sampling
Using Artificial Intelligence to Predict Contamination During Formation Fluid Sampling
Formation fluid samples acquired using advanced wireline or LWD tools are the most representative because the reservoir fluid is maintained in single phase all throughout the acqui...

Back to Top